Point-of-care diagnostics for G6PD deficiency play a critical role in supporting appropriate treatment of P. vivax malaria and efforts to eliminate the disease.
PATH is working with partners to develop and bring to market a portfolio of diagnostic tests for G6PD deficiency to help guide appropriate clinical care and support of P. vivax elimination.
Please see the link below for more details